International Clinical Trial: Efficacy of umbilical cord mesenchymal stem cell-derived exosome encapsulated hydrogel in the treatment of diabetic foot wounds: a multicenter, randomized, open-label clinical study

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118237) titled 'Efficacy of umbilical cord mesenchymal stem cell-derived exosome encapsulated hydrogel in the treatment of diabetic foot wounds: a multicenter, randomized, open-label clinical study' on Feb. 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University

Condition: Diabetic foot

Intervention: Experimental group:Umbilical cord mesenchymal stem cell-derived exosome encapsulated hydrogel

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2024-01-12

Target Sample Size: Experimental group:42;Control group:42;

Countries o...